【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Product profile
• REVLIMID
• VIDAZA
• Dacogen
• Glivec/Gleevec
PART 04: Market research methodology
• Research methodology
• Economic indicators
PART 05: Introduction
• Key market highlights
PART 06: Disease overview
• Understanding the disease
• Risk factors
• Signs and symptoms
• Pathophysiology
• Types
• Diagnosis
• Epidemiology
• Treatment
PART 07: Pipeline portfolio
• Information on pipeline candidates
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by drug class
• Alkylating agents
• Cytotoxic antibiotics
• Topoisomerase inhibitors
• Others
PART 10: Market segmentation by route of administration
• Oral
• Parenteral
PART 11: Geographical Segmentation
• Myelodysplastic syndrome market in EMEA
• Myelodysplastic syndrome market in APAC
PART 12: Market drivers
• Rise in aging population
• Unmet medical needs
• Use of diagnostic tools
PART 13: Impact of drivers
PART 14: Market challenges
• Use of off-label drugs
• Adverse effects of drugs
• High cost of drugs
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Rise in public awareness
• Patient assistance programs
• Increase in R&D
• Intense competition
PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2014
• Other prominent vendors
PART 18: Key vendor analysis
• Celgene
• Novartis
• Otsuka Holdings
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Myelodysplastic syndrome: Risk factors
Exhibit 03: Myelodysplastic syndrome: Signs and symptoms
Exhibit 04: History of myelodysplastic syndrome classification system
Exhibit 05: FAB classification system: Types of myelodysplastic syndrome
Exhibit 06: WHO classification system: Types of myelodysplastic syndrome
Exhibit 07: IPSS classification: Factors and score
Exhibit 08: IPSS-R classification: Cytogenetic score
Exhibit 09: IPSS-R classification: Score values
Exhibit 10: IPSS-R classification: Risk categories and scores
Exhibit 11: Diagnostic tests for myelodysplastic syndrome
Exhibit 12: Myelodysplastic syndrome: Global incidence based on age 2007-2011 (years)
Exhibit 13: Myelodysplastic syndrome: Incidence in US by race 2007-2011
Exhibit 14: Treatment options for myelodysplastic syndrome
Exhibit 15: Chemotherapeutic agents
Exhibit 16: Immunotherapy drugs
Exhibit 17: Supportive therapy for myelodysplastic syndrome
Exhibit 18: Drugs that received orphan designation for treatment of myelodysplastic syndrome
Exhibit 19: Myelodysplastic syndrome: Drug pipeline
Exhibit 20: Global myelodysplastic syndrome market ($ millions)
Exhibit 21: Five forces analysis
Exhibit 22: Global myelodysplastic syndrome market segmentation by drug class
Exhibit 23: Global myelodysplastic syndrome market segmentation by route of administration
Exhibit 24: Global myelodysplastic syndrome market segmentation by geography 2014
Exhibit 25: Myelodysplastic syndrome market in Americas 2014-2019 ($ millions)
Exhibit 26: Myelodysplastic syndrome market in EMEA 2014-2019 ($ millions)
Exhibit 27: Myelodysplastic syndrome market in APAC 2014-2019 ($ millions)
Exhibit 28: Global myelodysplastic syndrome market segmentation by geography 2014-2019 ($ millions)
Exhibit 29: Impact of drivers
Exhibit 30: Impact of drivers and challenges
Exhibit 31: Ranking of leading companies
Exhibit 32: Celgene: YoY growth and revenue of VIDAZA 2012-2014 ($ millions)
Exhibit 33: Celgene: YoY growth and revenue of REVLIMID 2012-2014 ($ billions)
Exhibit 34: Celgene: Key takeaways
Exhibit 35: Otsuka Holdings: Key takeaways
Exhibit 36: Novartis: Key takeaways
Exhibit 37: Celgene: Product segmentation by revenue 2014
Exhibit 38: Celgene: Product segmentation by revenue 2013 and 2014
Exhibit 39: Celgene: Geographical segmentation by revenue 2014
Exhibit 40: Novartis: Business segmentation by revenue 2014
Exhibit 41: Novartis: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 42: Novartis: Geographical segmentation by revenue 2014
Exhibit 43: Otsuka Holdings: Business segmentation by revenue 2014
Exhibit 44: Otsuka Holdings: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 45: Otsuka Holdings: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル：骨髄異形成症候群（MDS）治療薬の世界市場2015-2019■ 英文：Global Myelodysplastic Syndrome Market 2015-2019
■ 発行日：2016年1月20日
■ 調査会社：Technavio
■ 商品コード：IRTNTR7587
■ 調査対象地域：グローバル
- 世界の再生医療装置市場動向（2012-2016）TechNavio's analysts forecast the Global Refurbished Medical Equipment market to grow at a CAGR of 7.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is reduced reimbursements for medical procedures. The Global Refurbished Medical Equipment market has also been witnessing the increased adoption of eco-friendly practices. However, concerns regarding qu …
- 動物医療の世界市場2015This new 42-page report from VPGMarketResearch.com analyzes global trends and strategies of the world’s leading animal health companies, including:Five-year forecasts for: - Major market segments - Key geographic regionsAssessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion …
- 飼料用酵素の世界市場：フィターゼ、プロテアーゼ、非澱粉性多糖類Feed enzymes accelerate the biochemical reactions in animals in order to support life. These enzymes are added to the feed of pig, poultry, cattle, and aquatic animals to enhance production efficiency. The major function of feed enzymes is to increase the digestibility of animals; for instance, phytase is used in the animal feed to break down the protein consumed by animals, which enhances their d …
- 企業向けモバイルアプリ開発サービスの世界市場About Global Enterprise Mobile App Development Services The enterprise mobile app development market provides many opportunities for app developers. Enterprises are expected to deploy mobile apps in their businesses at an aggressive rate as mobile apps intended for office use are aimed at improving business productivity in addition to enhancing communication and faster exchange of data. Trend of e …
- 世界のターボチャージャー市場動向及び予測：可変ノズルターボ、VGターボ、ウェイストゲート、ツインターボThe biggest challenge faced by the global automotive industry is meeting the regulations and standards set regarding the emissions of exhaust gases such as Carbon Dioxide (CO2), Nitrous Oxide (NOx) and Particulate Material (PM) from automobiles. Another challenge is increasing demand for fuel-efficient vehicles from consumers as well as governments. These challenges have led to the OEMs and compon …
- HVAC（空調）絶縁の世界市場2016-2020：発泡プラスチック、ウールAbout HVAC Insulation Heating, ventilation, and air conditioning (HVAC) is one of the most energy-intensive systems in commercial and residential buildings. HVAC insulation is crucial to the energy efficiency, performance, and sustainability of HVAC systems. HVAC insulation helps in controlling the heat that is dissipated through conduction, convection, and radiation. Apart from their unique therm …
- たばこ製造・販売企業分析：British American Tobacco (BAT)Synopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: British American Tobacco (BAT), including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio, as well as a …
- Continental Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 収益サイクル管理 (RCM) の世界市場予測（～2021）：製品別（統合型RCM、独立型RCM）、構成要素別、導入別、需要先別、地域別The global revenue cycle management market is projected to reach USD 80.56 Billion by 2021 from USD 45.52 Billion in 2016, growing at a CAGR of 12.1% during the forecast period. Growth in the market is driven by the regulatory compliance encouraging the use of RCM solutions, government support, increasing number of patients, and process improvements in healthcare organizations brought about by RCM …
- 世界のSCMソフトウェア市場動向（2012-2016）TechNavio's analysts forecast the Global SCM Software market to grow at a CAGR of 10.58 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for companies to improve their efficiency. The market has also been witnessing the development and adoption of supply chain visibility and event management. However, vendor and partner relationship issues co …
- 2014年戦略提言：日本の病院血液及びフローサイトメトリー市場This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including: Major issues pertaining to the Japanese hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the nex …
- プロテインエンジニアリングの世界市場：プロテインエンジニアリング技術、製品（機器、サービス）、蛋白質種類、需要先、地域別分析Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions. The report segments the global protein engineering market product, technology, protein type, end user, and region. Instruments accounted for the largest share of the global Protein engineering market, by product in 20 …
- ホログラフィックディスプレイの世界市場：カメラ、デジタル・サイネージ、キオスク、医療画像機器、ノートPC、スマートテレビ等Holographic display is a technology in which the information is stored and retrieved in three demotions and can be reconstructed later for projection or display. A spatial light modulator is used to reconstruct the 3D objects for 2D or 3D screens. The holographic displays offer realistic full-color images with extremely high resolution. This display technology is mainly used to project (or show) t …
- 2014年戦略提言：スペインの治療薬物モニタリング(TDM)市場This new 249-page report from Venture Planning Group provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carb …
- オーディオコーデックの世界市場予測（～2022）The audio codec market was valued at USD 5.49 Billion in 2015 and is expected to reach USD 7.44 Billion by 2022, at a CAGR of 4.3% between 2016 and 2022. The growth of the market is driven by the factors such as increasing Internet penetration and data traffic and growing mobile phone subscription. In almost all the regions, the consumer’s pattern is changing with the emergence of connected life i …
